Procurement Summary
Country: USA
Summary: Dow Breast Cancer, Breakthrough Award Levels 1 And 2
Deadline: 08 Jul 2026
Posting Date: 05 May 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140656013
Document Ref. No.: HT942526BCRPBTA12
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Summary: The Fiscal Year 2026 (Fy26) Breast Cancer Research Program (Bcrp) Breakthrough Award Mechanism Supports Promising Research With High Potential To Lead To Or Make Breakthroughs In Breast Cancer. All Applications Must Address At Least One Of The Fy26 Bcrp Overarching Challenges Or Provide Adequate Justification For Exception. Applications Must Address The Challenge In A Way That Can Lead To A Breakthrough And Have Major Impact. The Fy26 Breakthrough Award Mechanism Contains Four Different Funding Levels Designed To Support Major (But Not All) Stages Of Research That Will Lead To Clinical Application. Each Level Specifies A Distinct Research Scope. This Program Announcement Discusses The Breakthrough Award Levels 1 And 2.Distinctive Features:· This Funding Mechanism Allows For Applications Submitted Under Funding Level 1 Or Funding Level 2. Funding Level 2 Also Includes A Population Science Studies Option. With Compelling Justification, Population Science Studies May Request Higher Levels Of Funding And An Additional Year In The Period Of Performance.· This Funding Mechanism Allows For A Single Principal Investigator (Pi), Or Two Partnering Pis Referred To As The Initiating Pi And The Partnering Pi. For The Partnering Pi Option (Ppio), Only The Initiating Pi Will Submit A Pre-Application, But Both Pis Will Need To Submit At The Full Application Stage. Be Advised, Failure To Sub...
Posted Date: 2026-05-04 00:00:00
Funding instrument type: Grant
Documents
Tender Notice